University of MelbourneMelbourne, Victoria, Australia
Disclosure(s): No financial relationships to disclose
86 - The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-< 70 years old.
Thursday, October 17, 202411:30 AM – 11:45 AM US PT